Trump Ramps Up Tariff Blitz With India, Pharma, Chips in Sights
6 Articles
6 Articles
Trump Ramps Up Tariff Blitz With India, Pharma, Chips in Sights
President Donald Trump said he’d impose increased tariffs on countries buying energy from Russia while clarifying that levies on semiconductor and pharmaceutical imports would be announced “within the next week or so.”
Trump Says Tariffs On Pharma, Chips Coming By "Next Week Or So"
US President Donald Trump signaled Tuesday that fresh tariffs on imported pharmaceuticals and semiconductors could be unveiled as soon as the coming week, as he presses on in efforts to reshape global trade.
Trump signals tariffs for pharma, chips
US President Donald Trump has signalled that fresh tariffs on imported pharmaceuticals and semiconductors could be unveiled within the coming week, amid a cascade of incoming duties. Governments around the world are bracing as new waves of US tariffs are due to take effect this week, first on many Brazilian products on Wednesday and then on dozens of other economies a day later. Trump's sweeping plans have sparked a flurry of activity as leaders…
Hours before the tariff rise to Brazilian imports came into effect, US President Donald Trump narrowed the siege on pharmaceuticals and India on Tuesday as he rushes negotiations with Switzerland, reports the AFP. Last week Trump signed a decree that raises customs tariffs to between [...] Trump's entry again threatens to raise tariffs to India and the pharmaceutical industry was first published in Information Focus.
Dow Jones Industrial Average Gains as Trump Hints at Tariffs on Chips and Pharma
Highlights Trump plans tariffs on semiconductors and pharmaceutical imports in coming days Dow Jones Industrial Average steady as S&P 500 and Nasdaq futures climb Swiss officials rush to U.S. to avoid new trade penalties The semiconductor and pharmaceutical sectors moved into the spotlight early Tuesday after President Trump announced intentions to implement fresh import tariffs within the week. The proposed measures could affect a broad rang…
Coverage Details
Bias Distribution
- 67% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium